Dopamine

Active ingredient: Dopamine Hydrochloride

In short: Dopamine HCl Injection is indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output.

Forms & strengthsThe following strengths of Dopamine HCL, USP, are supplied in single-dose vials (the solution is clear practically colorless): 200 mg/5 mL (40 mg/mL) 400 mg/10 mL (40 mg/mL) 400 mg/5 mL (80 mg/mL) 800 mg/10 mL (80 mg/mL)
LabelProPharma Distribution
Label updatedJul 21, 2025

What is Dopamine used for?

Dopamine HCl Injection is indicated to improve hemodynamic status in patients in distributive shock or shock due to reduced cardiac output.

Dopamine dosage

Correct Hypovolemia, Acidosis, and Hypoxia

Address hypovolemia, acidosis, and hypoxia before initiating Dopamine HCl Injection. If patient does not respond to therapy, suspect occult hypovolemia. Acidosis may reduce the effectiveness of dopamine

.

Preparation

For the 40-mg/mL preparation, transfer by aseptic technique the contents containing either 5 mL (200 mg) or 10 mL (400 mg) of Dopamine HCl Injection to either a 250-mL or a 500-mL bottle of one of the sterile intravenous solutions listed below:

0.9% Sodium Chloride Injection, USP

5% Dextrose Injection, USP

5% Dextrose and 0.9% Sodium Chloride Injection, USP

5% Dextrose and 0.45% Sodium Chloride Injection, USP

5% Dextrose and Lactated Ringer’s Injection

Sodium Lactate Injection, USP 1/6 Molar

Lactated Ringer’s Injection, USP

The resultant dilutions are summarized in the following chart:

Dopamine HCl Injection has been found to be stable for 24 hours after dilution in the foregoing intravenous solutions.

Administration

Dopamine HCl Injection is administered (only after dilution) by intravenous infusion.

Administer Dopamine HCl Injection into a large vein

with the use of an infusion pump preferably in an intensive care setting.

Inspect Dopamine HCl Injection for particulate matter and discoloration prior to administration whenever solution and container permit (the solution is clear, practically colorless). Do not administer if the solution is darker or discolored.

Use higher concentration solutions (e.g., 3200 mcg/mL or 1600 mcg/mL strengths) in patients requiring fluid restriction.

Discontinuation

When discontinuing Dopamine HCl Injection, gradually reduce the infusion rate while expanding blood volume with intravenous fluids

.

The recommended starting dosage in adults and pediatric patients is 2 to 5 mcg/kg/minute as a continuous intravenous infusion

. Titrate the infusion rate in increments of 5 to 10 mcg/kg/minute based on hemodynamic response and tolerability, but do not exceed 50 mcg/kg/minute.

Infusion rates may be calculated using the following formula:

Example calculations for infusion rates are as follows:

Example 1:for a 60 kg person at the recommended initial dose of 2 mcg/kg/minute using a 800 mcg/mL concentration, the infusion rate would be as follows:

Example 2:for a 70 kg person at a dose of 5 mcg/kg/minute using a 1600 mcg/mL concentration, the infusion rate would be as follows:

Dopamine HCl Injection is incompatible with the following products; therefore, avoid simultaneous administration (through the same infusion set):

Sodium bicarbonate or other alkalinizing substances, because dopamine is inactivated in alkaline solution

Blood, because of the risk of pseudoagglutination of red cells

Iron salts

Do not add additional medications in the diluted infusion solution.

How to take Dopamine — instructions & advice from the label

Risk of Tissue Damage

Advise the patient, family, or caregiver to report signs of extravasation urgently

.

Warnings & precautions

Do not take this medicine if: Dopamine is contraindicated in patients with pheochromocytoma.

Administration of dopamine to patients who are hypotensive from hypovolemia can result in severe peripheral and visceral vasoconstriction, decreased renal perfusion and hypouresis, tissue hypoxia, lactic acidosis, and poor systemic blood flow despite “normal” blood pressure. Address hypovolemia prior to initiating Dopamine HCl Injection

.

Gangrene of the extremities has occurred in patients with occlusive vascular disease or who received prolonged or high dose infusions. Monitor for changes to the skin of the extremities in susceptible patients.

Extravasation of Dopamine HCl Injection may cause necrosis and sloughing of surrounding tissue. To reduce the risk of extravasation, infuse into a large vein

, check the infusion site frequently for free flow, and monitor for signs of extravasation.

Emergency Treatment of Extravasation

To prevent sloughing and necrosis in areas in which extravasation has occurred, infiltrate the ischemic area as soon as possible, using a syringe with a fine hypodermic needle with:

5 to 10 mg of phentolamine mesylate in 10 to 15 mL of 0.9% Sodium Chloride Injection in adults

0.1 to 0.2 mg/kg of phentolamine mesylate up to a maximum of 10 mg per dose in pediatric patients.

Sympathetic blockade with phentolamine causes immediate and conspicuous local hyperemic changes if the area is infiltrated within 12 hours.

Dopamine may cause arrhythmias. Monitor patients with arrhythmias and treat appropriately.

Sudden cessation of the infusion may result in marked hypotension. Gradually reduce the infusion rate while expanding blood volume with intravenous fluids. …

Dopamine side effects

The following adverse reactions are described elsewhere in the labeling:

Tissue Ischemia

Cardiac Arrhythmias

Hypotension

Severe Hypersensitivity Reactions

The following adverse reactions have been identified during postapproval use of dopamine. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Cardiac Disorders:anginal pain, palpitation

Gastrointestinal Disorders:nausea, vomiting

Metabolism and Nutrition Disorders:azotemia

Nervous System Disorders: headache, anxiety

Respiratory Disorders

:dyspnea

Skin and Subcutaneous Tissue Disorders: piloerection

Vascular Disorders: hypertension

Drug interactions

See Table 1 for clinically significant drug interactions with dopamine.

Table 1: Clinically Significant Drug Interactions with Dopamine

Halogenated Anesthetics

Clinical Impact: | Concomitant use may increase cardiac autonomic irritability and can sensitize the myocardium to the action of dopamine which may lead to ventricular arrhythmias and hypertension.

Intervention: | Monitor cardiac rhythm.

Examples: | desflurane, enflurane, isoflurane, and sevoflurane.

MAO Inhibitors

Clinical Impact: | Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine which may result in severe hypertension and cardiac arrhythmia.

Intervention: | Reduce the recommended starting dosage to no greater than one-tenth (1/10) of the recommended dose in patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of Dopamine HCl Injection.

Examples: | isocarboxazid, phenelzine, tranylcypromine, rasagiline, selegiline, linezolid.

Tricyclic Antidepressants

Clinical Impact: | Concomitant use may potentiate the cardiovascular effects of dopamine (e.g., hypertension).

Intervention: | Monitor blood pressure.

Examples: | amitriptyline, desipramine, doxepin, imipramine, nortriptyline. …

About this medicine

Dopamine, a sympathomimetic amine vasopressor, is the naturally occurring immediate precursor of norepinephrine. Dopamine hydrochloride is a white to off-white crystalline powder, which may have a slight odor of hydrochloric acid. It is freely soluble in water and soluble in alcohol. Dopamine HCl is sensitive to alkalies, iron salts, and oxidizing agents. Chemically it is designated as 4-(2-aminoethyl) pyrocatechol hydrochloride, and its molecular formula is C

8H

11NO

2• HCl. Dopamine HCl has a molecular weight of 189.64 and it has the following structural formula:

Dopamine (also referred to as 3 hydroxytyramine) is a naturally occurring endogenous catecholamine.

Dopamine hydrochloride injection is a clear, practically colorless, sterile, pyrogen-free, aqueous solution of dopamine HCl for intravenous infusion after dilution. Each milliliter of the 40 mg/mL preparation contains 40 mg of dopamine hydrochloride (equivalent to 32.31 mg of dopamine base). …

Disclaimer: This page is for general information only and is not medical advice. It is a condensed summary of the official FDA-approved label — it does not replace the full prescribing information or the advice of your doctor or pharmacist. Always follow your prescriber's instructions and read the medication guide that comes with your medicine.

Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 38431050-007e-41b2-e063-6394a90a1d64. Read the full official label on DailyMed.